María Florencia Gottardo

National University of Quilmes — Argentina

Medicine · Health Sciences

11h-index371citations32works0.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

GDF15 and Related Biomarkers(10), Cancer Cells and Metastasis(4), Nutrition and Health in Aging(4), Growth Hormone and Insulin-like Growth Factors(4), Estrogen and related hormone effects(4)

Publications32 total

Baculovirus-Mediated Gene Therapy: Targeting BIRC6 for Lung and Breast Cancer
Viruses·2025Open Access
Repurposing hemostatic drug desmopressin in AVPR2-expressing triple-negative breast cancer: Target expression analysis and preclinical antineoplastic effects on tumor growth and metastatic progression.
Journal of Clinical Oncology·2024· 1 cited
Exploring the Role of the Inhibitor of Apoptosis BIRC6 in Breast Cancer: A Database Analysis
JCO Clinical Cancer Informatics·2022· 5 cited
Propranolol blocks osteosarcoma cell cycle progression, inhibits angiogenesis and slows xenograft growth in combination with cisplatin-based chemotherapy
Scientific Reports·2022· 21 citedOpen Access
Exploring the metastatic role of the inhibitor of apoptosis BIRC6 in Breast Cancer
2021Open Access
Mitochondrial humanin peptide acts as a cytoprotective factor in granulosa cell survival
Reproduction·2021· 9 citedOpen Access
Preclinical efficacy of CIGB-300, an anti-CK2 peptide, on breast cancer metastasic colonization
Scientific Reports·2020· 23 citedOpen Access
Abstract 5983: p38 kinase acts as a negative regulator of recurrence after surgery in a mammary carcinoma model, through apoptosis induction and proliferation inhibition
Cancer Research·2020
Abstract 6232: Preclinical efficacy of CIGB-300, an anti-CK2 peptide, on breast cancer metastasic colonization
Cancer Research·2020
Abstract 2649: Isolation and characterization of novel murine mammary cell line with dormant phenotype and identification of new potential targets by mass spectrometry
Cancer Research·2020
Humanin Promotes Tumor Progression in Experimental Triple Negative Breast Cancer
Scientific Reports·2020· 43 citedOpen Access
Papel del péptido mitocondrial humanina como blanco terapéutico en cáncer y neurodegeneración
Nova·2019· 3 citedOpen Access
Papel del péptido mitocondrial humanina como blanco terapéutico en cáncer y neurodegeneración
SHILAP Revista de lepidopterología·2019Open Access
Isolation and characterization of murine mammary cell lines with differentiated aggressive phenotype
Medicina-buenos Aires·2019
Mitochondrial-derived peptide humanin as therapeutic target in cancer and degenerative diseases
Expert Opinion on Therapeutic Targets·2018· 49 cited
Abstract 78: p38 kinase is a negative regulator of tumorigenesis and recurrence after surgery in a mammary carcinoma model
Cancer Research·2018· 1 cited
Abstract 5118: Development of new alternative <i>in vivo</i> models to study early metastasic dissemination in breast cancer
Cancer Research·2018
Abstract 3132: Therapeutic blockade of Foxp3 in experimental breast cancer: Immune stimulation and direct antitumor effects
Cancer Research·2018
Abstract 1951: Role of mitochondrial peptide Humanin in the response of experimental breast cancer to chemotherapy
Cancer Research·2018· 1 cited
Abstract 2899: Antitumor activity of CIGB-300, a peptide CK2 inhibitor, in breast cancer models
Cancer Research·2018
page 1 of 2Next →

Frequent Co-authors

Adriana Seilicovich(19), Marianela Candolfi(15), Antonela S. Asad(10), Hernán G. Fariña(10), Mariela A. Moreno Ayala(9), Camila Florencia Zuccato(9), Gabriela Jaita(9), Daniel F. Alonso(9), Alejandro J. Nicola Candia(8), Carla S. Capobianco(8), Johanna E. Sidabra(8), Matías L. Pidre(7), Vı́ctor Romanowski(7), Daniel Pisera(7), María Laura Magri(6), Jimena Ferraris(6), Guadalupe Eijo(6), Mercedes Imsen(5), Mariela Moreno Ayala(5), Sandra Zárate(4)